| Product |
Antigen Tests
|
|---|---|
| Description of Project |
This contract was awarded to DiaSorin Inc. to increase its production capacity of LIAISON SARS-CoV-2 TrimericS IgG tests. |
| Unique Impact |
This industrial base expansion effort will allow DiaSorin Inc. to increase its production capacity of LIAISON SARS-CoV-2 TrimericS IgG tests from 1.3 million tests per month to 10 million per month by May 2022. |
| Base Award Amount |
$4,624,729.00
|
| Category |
Testing Capacity and Raw Materials
|
Official websites use .gov
A .gov website belongs to an official government organization in the United
States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely
connected to the .gov website. Share sensitive information only on official, secure websites.
